as on September 18, 2025 at 1:29 am IST
Day's Low
Day's High
0.66%
Downside
1.45%
Upside
52 Week's Low
52 Week's High
26.45%
Downside
8.09%
Upside
Check Resmed Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$39.9B
EPS (TTM)
9.5009
Dividend Yield
0.81%
Quarterly Earnings Growth YOY
0.30%
PE Ratio (TTM)
28.66
Industry PE ratio
16.65525641025641
P/B Ratio
28.6646
PEG Ratio
1.8363
EBITDA
1.9B
Revenue (TTM)
5.1B
Profit Margin
27.22%
Return On Equity TTM
25.86%
Track how Resmed Inc. P/E has moved over time to understand its valuation trends.
Resmed Inc. in the last 5 years
Lowest (22.59x)
December 31, 2023
Industry (16.66x)
September 17, 2025
Today (28.66x)
September 17, 2025
Highest (49.09x)
September 30, 2021
Today’s Price to Earnings Ratio: 28.66x
Compare market cap, revenue, PE, and other key metrics of Resmed Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $39.9B | 56.86% | 28.66 | 27.22% | |
BUY | $155.8B | 91.45% | 60.6 | 28.51% | |
BUY | $38.5B | 31.35% | 35.84 | 10.70% | |
BUY | $18.6B | -6.04% | 38.62 | 16.48% | |
BUY | $53.4B | -18.26% | 34.1 | 7.41% |
The Resmed Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Resmed Inc. investment value today
Current value as on today
₹1,12,941
Returns
₹12,941
(+12.94%)
Returns from Resmed Inc. Stock
₹8,343 (+8.34%)
Dollar Returns*
₹4,598 (+4.6%)
Based on 19 analysts
63.16%
Buy
36.84%
Hold
0.00%
Sell
Based on 19 analysts, 63.16% of analysts recommend a 'BUY' rating for Resmed Inc.. Average target price of $290.46
Get share price movements and forecasts by analysts on Resmed Inc..
What analysts predicted
6.42%UPSIDE
Target Price
$290.46
Current Price
$271.81
Analyzed by
19 Analysts
Target
$290.46
Resmed Inc. target price $290.46, a slight upside of 6.42% compared to current price of $271.81. According to 19 analysts rating.
Search interest for Resmed Inc. Stock has decreased by -24% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Check out the Mutual Funds with significant holdings in Resmed Inc..
Today's Timeline - 12 September
Fri, 03:14 PM
-ResMed reports Q2 revenues of $1.35 billion, exceeding expectations by 1.3% and reflecting strong demand for sleep and breathing health devices.
Sat, 08:01 AM
-ResMed's stewardship presentation highlights FY 2025 revenue of $5.1B and commitment to empowering 500 million lives by 2030.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Resmed Inc. has shown consistent growth in its net profit over the last five quarters. The net profit increased from $292.23 million to $379.70 million, with an average rise of 6.3% each quarter.
Revenue Rich
Resmed Inc. has shown consistent growth in its revenue over the last eight quarters. The revenue increased from $963.03 million to $1.34 billion, resulting in an average quarterly growth rate of 4.5%.
Best in 3 Years
In the last 3 years, RMD has outperformed top 5 stocks with highest market-cap in its industry
Best in 1 Year
In the last 1 year, RMD has outperformed top 5 stocks with highest market-cap in its industry
Price Dip
In the last 1 month, RMD stock has moved down by -4.3%
Organisation | Resmed Inc. |
Headquarters | 9001 Spectrum Center Boulevard, San Diego, CA, United States, 92123 |
Industry | Health Technology |
CEO | Mr. Michael J. Farrell BE, MBA, SM |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Ms. Sallilyn Schwartz | Chief Investor Relations Officer |
Mr. Jim Ellis | Chief Compliance Officer |
Ms. Yvonne-Katrin Pucknat | Chief Marketing Officer |
Ms. Vered Keisar | Chief People Officer |
Mr. Michael J. Farrell BE, MBA, SM | CEO & Chairman |
Mr. Michael J. Rider | Chief Legal Officer & Secretary |
Mr. Justin Leong | Chief Product Officer |
Dr. Peter C. Farrell A.M., B.E., BE (Hons), Ph.D., ScD | Founder, Chair Emeritus & Director |
Mr. Brett A. Sandercock | Chief Financial Officer |
Mr. Alastair Robertson | Chief Information Officer |
Resmed Inc. share price today is $271.81 as on at the close of the market. Resmed Inc. share today touched a day high of $275.75 and a low of $270.02.
Resmed Inc. share touched a 52 week high of $293.81 on and a 52 week low of $199.92 on . Resmed Inc. stock price today i.e. is closed at $271.81,which is 7.49% down from its 52 week high and 35.96% up from its 52 week low.
Resmed Inc. market capitalisation is $0.04T as on .
Indian investors can start investing in Resmed Inc. (RMD) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Resmed Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Resmed Inc. share’s latest price of $271.81 as on September 18, 2025 at 1:29 am IST, you will get 0.0368 shares of Resmed Inc.. Learn more about
fractional shares .
Resmed Inc. stock has given 56.86% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?